BCL6
BCL6 (B-cell lymphoma 6 protein, also known as ZBTB27, LAZ3, BCL5, BCL6A and ZNF51) is a nuclear zinc finger transcription repressor. It is required for germinal centre formation and antibody affinity maturation, and acts with corepressors and histone deacetylases. Browse Assay Genie's current range of BCL6 research reagents below, or read on for the biology behind the target.
BCL6 is a transcriptional repressor mainly required for germinal centre (GC) formation and antibody affinity maturation. It forms complexes with different corepressors and histone deacetylases to repress distinct subsets of target genes. It binds DNA directly at the sequence 5'-TTCCTAGAA-3', the BCL6-binding site, or acts indirectly by repressing the activity of other transcription factors. In GC B-cells it represses genes involved in differentiation, inflammation, apoptosis and cell cycle control, and it autoregulates its own expression.
A key role of BCL6 is to let GC B-cells proliferate rapidly in response to T-cell dependent antigens. It also lets them tolerate the physiological DNA breaks needed for immunoglobulin class switch recombination and somatic hypermutation, without triggering a p53/TP53-dependent apoptotic response. BCL6 indirectly up-regulates genes important for GC reactions, such as AICDA, by repressing microRNAs such as miR155. In follicular helper CD4(+) T-cells it promotes T(FH)-related genes while inhibiting T(H)1, T(H)2 and T(H)17 differentiation, and it is required for immunological memory in both T- and B-cells. It suppresses macrophage proliferation by competing with STAT5 for binding motifs on targets such as CCL2 and CCND2, and it controls neurogenesis by altering NOTCH-dependent complexes at targets such as HES5, including recruitment of SIRT1.
The BCL6 gene encodes a zinc finger protein with an N-terminal POZ domain, which interacts with POZ-containing corepressors. It belongs to the C2H2-type zinc finger and BTB domain-containing gene groups. The protein modulates STAT-dependent IL-4 responses in B cells. The gene is frequently translocated and hypermutated in diffuse large-cell lymphoma (DLCL) and may contribute to its pathogenesis. Alternatively spliced transcript variants encode different isoforms. The mouse ortholog is Bcl6.
BCL6 is required for germinal centre formation and antibody affinity maturation, making it central to studies of B-cell responses.
The BCL6 gene is frequently translocated and hypermutated in diffuse large-cell lymphoma and may be involved in its pathogenesis.
BCL6 promotes follicular helper T-cell genes while inhibiting T(H)1, T(H)2 and T(H)17 differentiation, and supports immunological memory.
BCL6 recruits corepressors and histone deacetylases to silence target genes, a model for studying BTB/POZ repressor mechanisms.
BCL6 is a nuclear transcriptional repressor. It binds DNA directly or acts through other transcription factors, recruiting corepressors and histone deacetylases. It is required for germinal centre formation and antibody affinity maturation, and it also functions in follicular helper T-cells, macrophages and neurogenesis.
BCL6 is also known as ZBTB27, LAZ3, BCL5, BCL6A and ZNF51. Earlier names include zinc finger protein 51 and B cell CLL/lymphoma 6. UniProt lists the protein as B-cell lymphoma 6 protein. Alternative splicing produces different protein isoforms.
The BCL6 gene is frequently translocated and hypermutated in diffuse large-cell lymphoma and may be involved in its pathogenesis. A mouse ortholog, Bcl6, exists; check the datasheet of any product for its validated reactivity.
Other BCL-named transcription regulators and apoptosis-related proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P41182; product specifications from Assay Genie datasheets.